ADC Therapeutics SA — 四半期キャッシュフロー (NYSE:ADCT) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 321.98 M272.54 M321.56 M289.76 M323.15 M 負債合計 524.62 M510.76 M520.75 M527.94 M508.98 M 純資産合計 -202.64 M-238.22 M-199.18 M-238.18 M-185.83 M 負債および純資産合計 321.98 M272.54 M321.56 M289.76 M323.15 M 有利子負債合計 113.63 M113.82 M114.47 M115.21 M115.45 M 純負債 -137.24 M-80.88 M-150.09 M-119.53 M-145.89 M

ニュース

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?

ADC Therapeutics SA 2025 Q4 - Results - Earnings Call Presentation (NYSE:ADCT) 2026-03-11

Micron and BioNTech among market cap stock movers on Tuesday

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates

【決算速報】Adc Thera、売上高は予想を上回り、利益は予想を上回る結果に

Adc Thera earnings beat by $0.20, revenue topped estimates

ADC Therapeutics、第4四半期売上高2230万ドルを報告

ADC Therapeutics reports Q4 revenue of $22.3 million

ADC Therapeuticsが公正価値目標到達で70%のリターンを実現

ADC Therapeutics delivers 70% return as Fair Value target hit

ADC TherapeuticsがTD Cowenで発表、リンパ腫治療における戦略的拡大

ADC Therapeutics at TD Cowen: Strategic Expansion in Lymphoma Treatment